[[STAGE]] Where are we in first line therapy for Hodgkin Lymphoma?

Where are we in first line therapy for Hodgkin Lymphoma?

E-session 633

Expert

Peter W.M. Johnson

Cancer Research UK Centre, Southampton General Hospital
Southampton, United Kingdom

Discussant

Astrid Pavlovsky

Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

This e-Session is part of the following pathway(s):

Sep 2022

ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.

The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de

Oncology education together via social media